1. 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. (23rd October 2018) Authors: Pohl, E; Schneeweiss, A; Hauke, J; Moebus, V; Furlanetto, J; Denkert, C; Fasching, P A; Hanusch, C; Tesch, H; Weber-Lassalle, N; Müller, V; Rhiem, K; Untch, M; Luebbe, K; Lederer, B; Jackisch, C; Nekljudova, V; Schmutzler, R K; Hahnen, E; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 273PD_PRFinal analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients. (23rd October 2018) Authors: Reinisch, M; Seiler, S; Hauzenberger, T; Schmatloch, S; Strittmatter, H-J; Zahm, D-M; Thode, C; Jackisch, C; Strik, D; Moebus, V; Reimer, T; Sinn, B; Stickeler, E; Marme, F; Janni, W; Kamischke, A; Rudlowski, C; Nekljudova, V; von Minckwitz, G; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients. (24th October 2018) Authors: Matikas, A; Foukakis, T; Moebus, V; Greil, R; Bengtsson, N -O; Steger, G G; Untch, M; Johansson, H; Hellström, M; Malmström, P; Gnant, M; Loibl, S; Bergh, J Journal: Annals of oncology Issue: Volume 30:Number 1(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗